![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61P 37/00 | (2006.01) |
A61K 31/416 | (2006.01) | ||
A61K 31/401 | (2006.01) | ||
C07D 401/14 | (2006.01) | ||
C07D 403/14 | (2006.01) |
(11) | Number of the document | 4129407 |
(13) | Kind of document | T |
(96) | European patent application number | 22193148.8 |
Date of filing the European patent application | 2015-02-25 | |
(97) | Date of publication of the European application | 2023-02-08 |
(45) | Date of publication and mention of the grant of the patent | 2024-12-25 |
(46) | Date of publication of the claims translation | 2025-02-25 |
(30) | Number | Date | Country code |
201461944189 P | 2014-02-25 | US | |
201462022916 P | 2014-07-10 | US | |
201462046783 P | 2014-09-05 | US |
(72) |
GADHACHANDA, Venkat Rao , US
WANG, Qiuping , US
PAIS, Godwin , US
HASHIMOTO, Akihiro , US
CHEN, Dawei , US
WANG, Xiangzhu , US
ARARWAL, Atul , US
DESHPANDE, Milind , US
WILES, Jason Allan , US
PHADKE, Avinash S. , US
|
(73) |
Achillion Pharmaceuticals, Inc. ,
121 Seaport Blvd., Boston, MA 02210,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Arilo, heteroarilo ir heterocikliniai junginiai, skirti komplemento nulemtiems sutrikimams gydyti |
ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS |
Payment date | Validity (years) | Amount | |
2025-01-22 | 11 | 289.00 EUR |
2026-02-25 |